Coromandel International Converts ₹108 Crore Loan to Equity in Wholly Owned Subsidiary
Coromandel International Limited converted a loan of ₹108.07 Crores, including accrued interest, into equity in its wholly-owned subsidiary, Coromandel Chemicals Limited. The conversion is at ₹39.95 per share. The transaction was approved by the Audit Committee and Board on July 23, 2026.
The conversion of a substantial loan into equity impacts the subsidiary's capital structure and the parent company's investment. It's a significant financial move within the group, hence medium impact.
The announcement details a routine financial transaction (loan to equity conversion) within a wholly-owned subsidiary. While it involves a significant amount, it's an internal restructuring and doesn't inherently signal growth or decline.
Coromandel International Limited has executed an agreement for the conversion of a loan, including accrued interest, amounting to ₹108.07 Crores into equity shares of its wholly-owned subsidiary, Coromandel Chemicals Limited. The conversion will occur at an issue price of ₹39.95 per equity share of face value ₹10 each.
This transaction, approved by the company's Audit Committee and Board on July 23, 2026, is considered a related party transaction but is undertaken on an arm's length basis. The original unsecured loan was executed on December 1, 2025, with ₹108.07 Crores outstanding, including accrued interest as of June 30, 2026. The conversion will result in the issuance of 2,70,52,132 equity shares.
No nominee director has been appointed through this agreement, and no conflict of interest arises beyond the disclosed related party relationship.
A plain-language summary of a public exchange filing by Coromandel International Limited. Read the original for the full detail.